Issn Print: 0923-7534
Publication Date: 2017/10/01
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L. A. Dunn; M. G. Fury; H. Xiao; S. S. Baxi; E. J. Sherman; S. Korte; C. Pfister; S. Haque; N. Katabi; A. L. Ho; D. G. Pfister
Author Information: Section of Head and Neck Oncology, Division of Solid Tumor, Department of Medicine;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.